European Neuropsychopharmacology

Papers
(The H4-Index of European Neuropsychopharmacology is 31. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
T58. EXPLORATION OF GENETIC AND CLINICAL HETEROGENEITY IN AUTISM BY CLUSTERING GENES BASED ON BULK AND SINGLE-CELL TRANSCRIPTOMIC DATA137
11. ESTABLISHING THE MOLECULAR FOUNDATION OF BRAIN ANATOMY IN LIVING INDIVIDUALS102
T47. A MULTI-OMIC QTL ANALYSIS OF MAJOR DEPRESSIVE DISORDER82
F41. AMBER: ANTIDEPRESSANT MEDICATIONS: BIOLOGY, EXPOSURE AND RESPONSE80
T84. AN INVESTIGATION ON GENETIC MECHANISMS UNDER CLINICAL HETEROGENEITY IN SCHIZOPHRENIA80
T56. DIP2A, HIGHLY EXPRESSED GENE IN THE CEREBELLUM, IS ASSOCIATED WITH A WIDE RANGE OF PSYCHIATRIC SYMPTOMS (DELAYED SPEECH, AUTISM SPECTRUM DISORDER AND SPECIFIC LEARNING DISABILITIES)79
T13. GENETIC ASSOCIATIONS OF ICD-DERIVED PSYCHIATRIC DIAGNOSES WITH SELF-REPORTED MENTAL HEALTH PHENOTYPES IN THE UK BIOBANK73
F8. THE DEVELOPMENTAL LANDSCAPE OF NEUROPSYCHIATRIC GENOMICS IN AFRICA62
T78. GENE-ENVIRONMENT INTERACTION STUDY ON THE CORRELATES FOR PSYCHOTIC EXPERIENCES IN THE UK BIOBANK60
T100. CHILD SUBCORTICAL BRAIN VOLUMES: THE INTERACTION BETWEEN GENETIC RISK AND MATERNAL PSYCHOLOGICAL DISTRESS DURING PREGNANCY59
F97. DIFFERENTIAL EXPRESSION OF MICRORNAS UPON IN VITRO LITHIUM AND VALPROATE EXPOSURE TO BIPOLAR DISORDER PATIENTS-DERIVED LCLS57
F75. PREDICTION OF TREATMENT-RESISTANT SCHIZOPHRENIA USING REAL-WORLD DATA AND MULTIMODAL ANALYTICAL TOOLS56
41. CHARACTERIZING FUNCTIONAL CONVERGENCE OF COMMON POLYGENIC VARIATION IN NEUROPSYCHIATRIC DISORDER RISK GENES50
85. DETECTION OF PLACENTAL SCHIZOPHRENIA RISK GENES47
1. DEVELOPMENTAL TRAJECTORIES OF DNA METHYLATION IN NEURAL CELL POPULATIONS IN HUMAN CORTEX AND LINKS TO NEURODEVELOPMENTAL DISORDERS47
T35. SHARED GENETIC LIABILITY FOR ALCOHOL CONSUMPTION, ALCOHOL PROBLEMS, AND SUICIDAL BEHAVIOR: EVALUATING THE ROLE OF IMPULSIVITY46
2. ENRICHMENT OF RARE, DAMAGING VARIANTS IN SCHIZOPHRENIA-RELATED GENES IN INTELLECTUAL DISABILITY PATIENTS WITH PSYCHOTIC DISORDERS46
T59. A GENOME-WIDE ASSOCIATION STUDY OF EATING DISORDER SYMPTOMS BASED ON THE SCOFF QUESTIONNAIRE45
T33. USING GENOMICS TO AID EARLY DIFFERENTIAL DIAGNOSIS BETWEEN BIPOLAR DISORDER AND MAJOR DEPRESSION45
T67. ASSOCIATIONS BETWEEN METHYLATION AGE AND BRAIN AGE IN LATE ADOLESCENCE43
Sodium nitroprusside enhances the antipsychotic-like effect of olanzapine but not clozapine in the conditioned avoidance response test in rats41
Clinical and psychopathological correlates of duration of untreated illness (DUI) in affective spectrum disorders40
6. DE NOVO MUTATIONS IN BIPOLAR DISORDER IMPLICATE GENES INVOLVED IN NEURODEVELOPMENT AND IMMUNITY40
A specific GPR56/ADGRG1 splicing isoform is associated with antidepressant response in major depressive disorder40
The effects of transient receptor potential cation channel inhibition by BI 1358894 on cortico-limbic brain reactivity to negative emotional stimuli in major depressive disorder40
F48. INVESTIGATING POTENTIAL RELATIONSHIPS BETWEEN PIGMENTATION GENETICS AND PARKINSON'S DISEASE (PD)39
Society Calendar37
HOW PARTICIPATING IN CAMH'S PHARMACOGENETICS IMPACT STUDY CHANGED MY LIFE36
W101. EPIGENETIC PROFILES OF LATENT CLASSES FOR POLYSUBSTANCE USE DISORDER36
F7. THE ASSOCIATIONS BETWEEN EDUCATIONAL EXPERIENCES AND MENTAL HEALTH FROM CHILDHOOD TO YOUNG ADULTHOOD33
W64. FAMILY BASED ASSOCIATION AND LINKAGE ANALYSES OF FAMILIAL ADHD31
POLYGENIC RISK SCORES FOR PROBLEMATIC SUBSTANCE USE IN ADOLESCENTS: AN ENIGMA-ADDICTION STUDY31
0.48787403106689